PortViewPortView
Soliton logo

Soliton (SOLY) Stock Analysis

NASDAQHealthcareMedical - Devices

$22.58+0.00%
1-year price historyRange $20.10 – $22.58
52-week range$22.58
$7.53$22.60

What Soliton does

Specializing in medical devices, Soliton, Inc. (SOLY) creates and markets products utilizing its unique rapid acoustic pulse technology platform. Their current offerings include solutions for tattoo removal, with active development underway for treatments targeting cellulite reduction, fibrotic scars, and additional medical applications. The company, established in Houston, Texas, in 2012, has operated as a subsidiary of Allergan plc since December 16, 2021.

Key metrics

Market cap
$0
P/E (TTM)
0.00
EPS (TTM)
$0.00
Beta
0.18
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$20.88
200-day avg
$20.64
52-week high
$22.60
52-week low
$7.53
CEO
Christopher C. Capelli

ETFs linked to SOLY

Broad-market and Healthcare sector ETFs an investor holding Soliton is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how SOLY fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze SOLY in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Soliton?
Soliton trades under the ticker SOLY on NASDAQ.
Which exchange is SOLY listed on?
SOLY is listed on NASDAQ.
What sector does Soliton operate in?
Soliton is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze SOLY in a portfolio?
PortView shows SOLY's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.